Mid Atlantic Financial Management’s Biogen BIIB Stock Holding History

Mid Atlantic Financial Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$211K	Buy	746 +109	+17%	+$35.7K	0.01%	807
2021 Q2	$221K	Sell	637 -216	-25%	-$65.4K	0.01%	797
2021 Q1	$239K	Sell	853 -55	-6%	-$14.8K	0.02%	720
2020 Q4	$222K	Buy	+908	New	+$234K	0.02%	688
2020 Q2	–	Sell	-1,423	Closed	-$450K	–	749
2020 Q1	$450K	Sell	1,423 -122	-8%	-$37K	0.05%	329
2019 Q4	$458K	Sell	1,545 -195	-11%	-$54.1K	0.04%	409
2019 Q3	$405K	Sell	1,740 -291	-14%	-$67.8K	0.04%	414
2019 Q2	$475K	Buy	2,031 +53	+3%	+$12.2K	0.05%	382
2019 Q1	$468K	Sell	1,978 -9	-0.5%	-$2.83K	0.05%	380
2018 Q4	$598K	Buy	+1,987	New	+$634K	0.07%	281

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mid Atlantic Financial Management's BIIB Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its Biogen (BIIB) stake by 17% in Q3 2021, buying an estimated $35.7K and bringing the position to 746 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #807.

Mid Atlantic Financial Management first reported a position in BIIB in Q4 2018 and has held it in 10 quarters since. The position peaked at $598K in Q4 2018. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

Mid Atlantic Financial Management held 746 shares of Biogen worth $211K as of Q3 2021.
Mid Atlantic Financial Management bought 109 Biogen shares in Q3 2021, an estimated $35.7K.
Biogen made up 0.01% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #807 holding.
Mid Atlantic Financial Management first reported a position in Biogen in Q4 2018 and has held it in 10 quarters since.
Mid Atlantic Financial Management's Biogen position peaked at $598K in Q4 2018.
1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.